Atlas Trials

5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)

Clinical trial NCT05577845 · RECRUITING

Trial details

NCT number
NCT05577845
Sponsor
Seoul National University Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
LARS - Low Anterior Resection Syndrome
Start date
2023-03-27
Primary completion
2025-12-01
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.